لوگو kmt موبایل

Hemophilia and its complications

Share This Post

17th April, World Hemophilia Day


Adapting to Change, sustaining care in a new world

World Hemophilia Day is an international awareness day for hemophilia and other bleeding disorders. It is held annually on April 17, date of the birthday of Frank Schnabel, founder of the World Federation of Hemophilia.

World Hemophilia Day is the day the whole bleeding disorders community comes together to celebrate the continuous advances in treatment while raising awareness and bringing understanding and attention to the issues related to proper care to the wider public.

Hemophilia is usually an inherited bleeding disorder in which the blood does not clot properly. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains many proteins called clotting factors that can help to stop bleeding. People with hemophilia have low levels of either factor VIII or factor IX. The severity of hemophilia that a person has is determined by the amount of factor in the blood. The lower the amount of the factor, the more likely it is that bleeding will occur which can lead to serious health problems.

In rare cases, a person can develop hemophilia later in life.  The majority of cases involve middle-aged or elderly people, or young women who have recently given birth or are in the later stages of pregnancy.  This condition often resolves with appropriate treatment.

Causes

Hemophilia is caused by a mutation or change, in one of the genes, that provides instructions for making the clotting factor proteins needed to form a blood clot. This change or mutation can prevent the clotting protein from working properly or to be missing altogether.

Hemophilia can result in:

  • Bleeding within joints that can lead to chronic joint disease and pain
  • Bleeding in the head and sometimes in the brain which can cause long term problems, such as seizures and paralysis
  • Death can occur if the bleeding cannot be stopped or if it occurs in a vital organ such as the brain.

Types

There are several different types of hemophilia. The following two are the most common:

  • Hemophilia A (Classic Hemophilia)
    This type is caused by a lack or decrease of clotting factor VIII.
  • Hemophilia B (Christmas Disease)
    This type is caused by a lack or decrease of clotting factor IX.

Signs and Symptoms

Common signs of hemophilia include:

  • Bleeding into the joints. This can cause swelling and pain or tightness in the joints; it often affects the knees, elbows, and ankles.
  • Bleeding into the skin (which is bruising) or muscle and soft tissue causing a build-up of blood in the area (called a hematoma).
  • Bleeding of the mouth and gums, and bleeding that is hard to stop after losing a tooth.
  • Bleeding after circumcision (surgery performed on male babies to remove the hood of skin, called the foreskin, covering the head of the penis).
  • Bleeding after having shots, such as vaccinations.
  • Bleeding in the head of an infant after a difficult delivery.
  • Blood in the urine or stool.
  • Frequent and hard-to-stop nosebleeds.

Who is Affected?

Hemophilia occurs in about 1 of every 5,000 male births. Based on recent study that used data collected on patients receiving care in federally funded hemophilia treatment centers during the period 2012-2018, about 20,000 as many as 33,000 males in the United States are living with the disorder. Hemophilia A is about four times as common as hemophilia B, and about half of those affected have the severe form. Hemophilia affects people from all racial and ethnic groups.

Diagnosis

Many people who have or have had family members with hemophilia will ask that their baby boys get tested soon after birth.
About one-third of babies who are diagnosed with hemophilia have a new mutation not present in other family members. In these cases, a doctor might check for hemophilia if a newborn is showing certain signs of hemophilia.
To make a diagnosis, doctors would perform certain blood tests to show if the blood is clotting properly. If it does not, then they would do clotting factor tests, also called factor assays, to diagnose the cause of the bleeding disorder. These blood tests would show the type of hemophilia and the severity.

Treatment

The best way to treat hemophilia is to replace the missing blood clotting factor so that the blood can clot properly. This is done by infusing (administering through a vein) commercially prepared factor concentrates. People with hemophilia can learn how to perform these infusions themselves so that they can stop bleeding episodes and, by performing the infusions on a regular basis (called prophylaxis), can even prevent most bleeding episodes.
Good quality medical care from doctors and nurses who know a lot about the disorder can help prevent some serious problems. Often the best choice for care is to visit a comprehensive Hemophilia Treatment Center (HTC). An HTC not only provides care to address all issues related to the disorder, but also provides health education that helps people with hemophilia stay healthy.

Prepared : Negin Ghafouri – Biomedical Engineering Student

Source : www.cdc.gov

Explore More

حضور گروه خسرو مدیسا طب در پنجمین همایش بین المللی تغذیه بالینی ایران
Events

Participation of KMT Group in the 5th International Clinical Nutrition Congress of Iran

16-18 Oct 2024 Iran University of Medical Sciences After successful experiences in holding four previous clinical nutrition congresses in the past decade, the Iran University of Medical Sciences (IUMS) will host the 5th International Clinical Nutrition Congress on October 16-18, 2024, with the main topic “Hospital Malnutrition: A Threat for

حضور گروه خسرو مدیسا طب در ایران مد 2024 + ویدیو
Events

The presence of KMT Group at IranMed 2024 + Video

10 – 13 Oct Tehran, IRAN KMT Group proudly participated once again in the IranMed 2024 event, held from October 10th to 13th. The IranMed exhibition, which focuses on medical, dental, laboratory, and pharmaceutical equipment, is a key event in the field of medical equipment in Iran. Khosro Medisa Teb